Literature DB >> 21295874

FDG-PET provides the best correlation with the tumor specimen compared to MRI and CT in rectal cancer.

Jeroen Buijsen1, Jørgen van den Bogaard, Marco H M Janssen, Frans C H Bakers, Stephanie Engelsman, Michel Öllers, Regina G H Beets-Tan, Marius Nap, Geerard L Beets, Philippe Lambin, Guido Lammering.   

Abstract

PURPOSE: To compare CT-, MR- and PET-CT based tumor length measurements in rectal cancer with pathology. PATIENTS AND METHODS: Twenty-six rectal cancer patients underwent both MR and PET-CT imaging followed by short-course radiotherapy (RT 5×5 Gy) and surgery within 3 days after RT. Tumor length was measured manually and independently by 2 observers on CT, MR and PET. PET-based tumor length measurements were also generated automatically using the signal-to-background-ratio (SBR) method. All measurements were correlated with the tumor length on the pathological specimen.
RESULTS: CT-based measurements did not show a valuable correlation with pathology. MR-based measurements correlated only weakly, but still significantly (Pearson correlation=0.55 resp. 0.57; p<0.001). Manual PET measurements reached a good correlation with pathology, but less strong (Pearson correlation 0.72 and 0.76 for the two different observers) than automatic PET-CT based measurements, which provided the best correlation with pathology (Pearson correlation of 0.91 (p<0.001)). Bland-Altman analysis demonstrated in general an overestimation of the tumor diameter using manual measurements, while the agreement of automatic contours and pathology was within acceptable ranges. A direct comparison of the different modalities revealed a significant better precision for PET-based auto-contours as compared to all other measurements.
CONCLUSION: Automatically generated PET-CT based contours show the best correlation with the surgical specimen and thus provide a useful and powerful tool to accurately determine the largest tumor dimension in rectal cancer. This could be used as a quick and reliable tool for target delineation in radiotherapy. However, a 3D volume analysis is needed to confirm these results.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21295874     DOI: 10.1016/j.radonc.2010.11.018

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  9 in total

Review 1.  Functional MRI for radiotherapy dose painting.

Authors:  Uulke A van der Heide; Antonetta C Houweling; Greetje Groenendaal; Regina G H Beets-Tan; Philippe Lambin
Journal:  Magn Reson Imaging       Date:  2012-07-06       Impact factor: 2.546

2.  PET/CT-based metabolic tumour volume for response prediction of neoadjuvant chemoradiotherapy in oesophageal carcinoma.

Authors:  Rachel L G M Blom; Inge R Steenbakkers; Guido Lammering; Roy F A Vliegen; Eric J Belgers; Charlotte de Jonge; Wendy M J Schreurs; Marius Nap; Meindert N Sosef
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-06-14       Impact factor: 9.236

Review 3.  Clinical application of multimodality imaging in radiotherapy treatment planning for rectal cancer.

Authors:  Yan Yang Wang; Hong Zhe
Journal:  Cancer Imaging       Date:  2013-12-11       Impact factor: 3.909

4.  18-Fluorodeoxy-Glucose Positron Emission Tomography- Computed Tomography (18-FDG-PET/CT) for Gross Tumor Volume (GTV) Delineation in Gastric Cancer Radiotherapy

Authors:  Kinga Dębiec; Jerzy Wydmański; Izabela Gorczewska; Paulina Leszczyńska; Kamil Gorczewski; Wojciech Leszczyński; Andrea d’Amico; Michał Kalemba
Journal:  Asian Pac J Cancer Prev       Date:  2017-11-26

Review 5.  Recent advances of PET imaging in clinical radiation oncology.

Authors:  M Unterrainer; C Eze; H Ilhan; S Marschner; O Roengvoraphoj; N S Schmidt-Hegemann; F Walter; W G Kunz; P Munck Af Rosenschöld; R Jeraj; N L Albert; A L Grosu; M Niyazi; P Bartenstein; C Belka
Journal:  Radiat Oncol       Date:  2020-04-21       Impact factor: 3.481

Review 6.  Precision Radiotherapy: 18F-FDG PET-based radiotherapy planning in Head and Neck cancers.

Authors:  Padma Subramanyam; Shanmuga Sundaram Palaniswamy; Shah Pervez Numani
Journal:  World J Nucl Med       Date:  2020-08-22

7.  The Potential Benefit by Application of Kinetic Analysis of PET in the Clinical Oncology.

Authors:  Mustafa Takesh
Journal:  ISRN Oncol       Date:  2012-12-26

8.  Diagnostic performance of 18F-FDG PET/CT using point spread function reconstruction on initial staging of rectal cancer: a comparison study with conventional PET/CT and pelvic MRI.

Authors:  Masatoshi Hotta; Ryogo Minamimoto; Hideaki Yano; Yoshimasa Gohda; Yasutaka Shuno
Journal:  Cancer Imaging       Date:  2018-01-30       Impact factor: 3.909

9.  FDG PET/CT for rectal carcinoma radiotherapy treatment planning: comparison of functional volume delineation algorithms and clinical challenges.

Authors:  Nadia Withofs; Claire Bernard; Catherine Van der Rest; Philippe Martinive; Mathieu Hatt; Sebastien Jodogne; Dimitris Visvikis; John A Lee; Philippe A Coucke; Roland Hustinx
Journal:  J Appl Clin Med Phys       Date:  2014-09-08       Impact factor: 2.102

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.